Cargando…
Cyclosporin A as a multidrug-resistant modulator in patients with renal cell carcinoma treated with teniposide.
Patients with refractory metastatic renal cell carcinoma (RCC) were enrolled in a phase II study with teniposide (VM26) and cyclosporin A (CSA) to investigate (1) the effect of CSA on the response rate to VM26; and (2) the effect of CSA on the pharmacokinetics and pharmacodynamics of VM26. Sixteen p...
Autores principales: | Toffoli, G., Sorio, R., Gigante, M., Corona, G., Galligioni, E., Boiocchi, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063346/ https://www.ncbi.nlm.nih.gov/pubmed/9043030 |
Ejemplares similares
-
Pharmacokinetics of doxorubicin co-administered with high-dose verapamil.
por: Gigante, M., et al.
Publicado: (1995) -
Pleiotropic-resistant phenotype is a multifactorial phenomenon in human colon carcinoma cell lines.
por: Toffoli, G., et al.
Publicado: (1991) -
Multidrug Resistance‐associated Protein‐mediated Multidrug Resistance Modulated by Cyclosporin A in a Human Bladder Cancer Cell Line
por: Kim, Wun‐Jae, et al.
Publicado: (1995) -
MiR-181b sensitizes glioma cells to teniposide by targeting MDM2
por: Sun, Yan-chang, et al.
Publicado: (2014) -
Patients treatment with neuroglioma by teniposide and semustine and its influence on Twist and E-cadherin expression
por: Zhang, Yongbo, et al.
Publicado: (2016)